Skip to content

Clinical trials

Phase 3 Amyotrophic Lateral Sclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 3 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20111
20121
20151
20162
20182
20192
20202
20212
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated7
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics4
Knopp Biosciences2
Orion Corporation, Orion Pharma2
ZevraDenmark2
Alector Inc.1
Alexion Pharmaceuticals, Inc.1
Biogen1
Ionis Pharmaceuticals, Inc.1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis18
Motor Neuron Disease3
Frontotemporal Dementia1
Muscle Cramp1
Neurodegenerative Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.